Novel Single-Tier Lyme Disease Tests Show Superior Early Detection
Two investigational diagnostics demonstrate significantly higher sensitivity than current CDC-recommended two-tier testing in Journal of Clinical Microbiology studies.
Two investigational diagnostics demonstrate significantly higher sensitivity than current CDC-recommended two-tier testing in Journal of Clinical Microbiology studies.
Study finds molecular signature identifies which men with recurrent disease respond to apalutamide plus salvage radiation therapy.
The Alzheimer's Association released its first clinical practice guideline on the use of blood-based biomarker tests.
On World Lung Day, Reveal Dx board member Mat Brevard discusses why current diagnostic tools fall short—and how new approaches could improve accuracy and outcomes.Â
The test uses Abbott's simpli-COLLECT platform to detect chlamydia, gonorrhea, trichomonas, and mycoplasma genitalium from patient-collected specimens.
Partnership provides mail-in semen analysis as a covered benefit for eligible members.
From rising demand for comprehensive IgE profiles to the emergence of molecular allergen diagnostics, laboratories are central to how clinicians prepare for and manage September’s asthma spike.
Lipoprotein(a), or Lp(a), is a genetically determined and under-recognized cardiovascular disease risk factor.
C2N Diagnostics has expanded the intended use of its PrecivityAD2 Alzheimer's disease blood test to include patients 50 years and older, lowering the previous age limit from 60 years.
It's essential to integrate point-of-care testing devices cautiously alongside traditional laboratory tests to ensure robust diabetes management.
The agreement aims to improve early detection and management of chronic kidney disease in underserved populations through integrated diagnostics and digital health solutions.
The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.
Washington University researchers are developing a rapid test to classify sepsis patients into inflammatory profiles for targeted treatment.